Australia's largest stock trading and investment forum Australia's #1 stock forum

RAP

Click for more information

0.00%

20.5¢ raptor resources limited

Conference Call Summary, page-520

Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #

First 520 Last

Share
Profile

Follow
Levelgrinder

1,612 Posts.

245

15/08/17

21:08

Post #: 26515977
Share

Originally posted by AlCp ↑

I agree, the double blind and randomize study is the FDA standard, but for one last time, the study/trial in Australia involves them enrolling random patient, the patient cough (they and the tester don't know if they have respiratory disease), and the application diagnosis it (either correctly or incorrectly) or was the study the other way around the patient has the disease, they cough (i.e. this could involve you so-called sham coughs as a placebo), and then the apps try to match it???? That's not how it works is it??????

But did it failed due to the quality of the data gathered is the question here........as mentioned by RAP????? Are you saying something is "dodgy" with what they are saying????

Expand

I think you need to use more question marks, to emphasis the point you are making. Just my opinion, do your own research etc.

RAP Price at posting: 7.6¢ Sentiment: Hold Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

Palladium's the newest geopolitical hot commodity. But ASX exposure is limited

MIN

Ellison slapped with $20M sanction from MinRes but will stay on as leader – for now

Week 44 Wrap: Relatively boring week ahead of US election; HotCopper's most watched; Oz inflation at 3.5%

MIN

Movers and Shakers: Zip Co, MinRes, Kuniko, more – The week's top ASX gainers

Bitcoin hits fresh record as instos pile into BTC ETFs – and Trump helps, too

There are more pages in this discussion • 57 more messages in this thread...

First 520 Last

Add RAP (ASX) to my watchlist